FINANCIAL ADVOCATES INVESTMENT MANAGEMENT – Eli Lilly and Company Transaction History
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT portfolio value:
$1.38M
portfolio value
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -18.52% | -1.43K shares | -1.12M | $323.35 | 6.30K |
| Q2 2022 | share | Increase | +75.30% | 3.32K shares | 1.24M | $324.23 | 7.74K |
| Q1 2022 | share | Decrease | -2.56% | -116 shares | 13K | $286.37 | 4.41K |
| Q4 2021 | share | Increase | +0.64% | 29 shares | 212K | $277.25 | 4.53K |
| Q3 2021 | share | Increase | +2.43% | 107 shares | 31K | $230.3 | 4.50K |
| Q2 2021 | share | Increase | +4.52% | 190 shares | 234K | $228.04 | 4.39K |
| Q1 2021 | share | Decrease | -3.53% | -154 shares | 39K | $184.81 | 4.20K |
| Q4 2020 | share | Increase | +4.08% | 171 shares | 116K | $166.32 | 4.36K |
| Q3 2020 | share | Decrease | -11.29% | -533 shares | -155K | $145.05 | 4.19K |
| Q2 2020 | share | Increase | +0.13% | 6 shares | 121K | $160.1 | 4.72K |
| Q1 2020 | share | Decrease | -7.96% | -408 shares | -19K | $134.64 | 4.71K |
| Q4 2019 | share | Increase | +3.81% | 188 shares | 121K | $126.91 | 5.12K |
| Q3 2019 | share | Increase | +3.11% | 149 shares | 22K | $107.36 | 4.93K |
| Q2 2019 | share | Increase | +20.24% | 806 shares | 13K | $105.74 | 4.78K |
| Q1 2019 | share | Decrease | -0.57% | -23 shares | 53K | $123.17 | 3.98K |
| Q4 2018 | share | Decrease | -27.22% | -1.49K shares | -127K | $109.26 | 4.00K |
| Q3 2018 | share | Increase | +12.21% | 599 shares | 170K | $100.8 | 5.50K |
| Q2 2018 | share | Increase | +0.47% | 23 shares | 43K | $79.72 | 4.90K |
| Q1 2018 | share | Decrease | -4.46% | -228 shares | -54K | $71.78 | 4.88K |
| Q4 2017 | share | Increase | 0.00% | 5.10K shares | 432K | $77.79 | 5.10K |